Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Beta Bionics Raises FY2025 Sales Guidance from $88.000M-$93.000M to $96.500M vs $91.355M Est

Author: Benzinga Newsdesk | October 28, 2025 03:04pm

Beta Bionics (NASDAQ:BBNX) raises FY2025 sales outlook from $88.000 million-$93.000 million to $96.500 million vs $91.355 million estimate.

Posted In: BBNX